What is the Non-prescription Mouthrinse market size?

The Non-prescription Mouthrinse market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Non-prescription Mouthrinse market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Non-prescription Mouthrinse market?

Increasing awareness of oral health and rising demand for preventive care drive the market.

What are the challenges facing the Non-prescription Mouthrinse market?

Stringent regulations and intense competition are key challenges in the market.

Which regions are leading the Non-prescription Mouthrinse market?

North America and Europe are the leading regions in the Non-prescription Mouthrinse market.

Who are the top companies in the Non-prescription Mouthrinse market?

Top companies include Colgate, Listerine, and Oral-B, among others.

What are the future opportunities in the Non-prescription Mouthrinse market?

Emerging markets and innovative products offer future opportunities for growth.

How does technology impact the Non-prescription Mouthrinse market?

Advances in technology improve product efficacy and user experience.

What is the regulatory landscape for the Non-prescription Mouthrinse market?

Regulations vary by region, with FDA and EU guidelines governing market approvals.

What is the future outlook for the Non-prescription Mouthrinse market?

The future outlook is positive, driven by increasing demand for oral care products.

Non-prescription Mouthrinse Strategic Analysis & Growth Outlook 2033

Non-prescription Mouthrinse by Application (Hypermarket and Supermarket, Convenience Stores, Online Sale), by Types (Alcoholic, Non-alcoholic), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Consumer Goods and Services🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $2018 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $2018 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Non-prescription Mouthrinse Market Overview

The Non-prescription Mouthrinse market refers to the segment of oral care products that are available over-the-counter, without the need for a doctor's prescription. As the Non-prescription Mouthrinse market size continues to grow, driven by increasing awareness of oral health and hygiene, the growth outlook and market forecast indicate a promising future for industry players. With a current market size of approximately $1.4 billion, the Non-prescription Mouthrinse market is expected to witness a compound annual growth rate (CAGR) of around 5-6% during the forecast period from 2026 to 2033, driven by macro drivers such as rising demand for oral care products and increasing adoption of preventive healthcare measures.

Loading chart…

The industry expansion is being shaped by key forces such as technology shifts towards more effective and natural ingredients, regulations governing the use of certain ingredients, and consumer behavior driven by increasing awareness of oral health. The largest region for the Non-prescription Mouthrinse market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific region. As the market continues to evolve, players must stay ahead of the curve by innovating and adapting to changing consumer needs and preferences, ultimately driving market forecast and growth outlook.

Report Overview

Report Attribute	Details
Market size value in 2025	2.02 billion
Revenue forecast in 2033	3.52 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Sunstar; P&G; Lion; Colgate-Palmolive; Unilever; Church & Dwight; PIERAS CO; GSK; Caldwell Consumer Health; Weleda; Dentyl Active; Kao Corporation; NYSCPS; WEIMEIZI (GUANGDONG) CO.; Reckitt Benckiser Group Plc; SmartMouth Oral Health Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non-prescription Mouthrinse market is poised for significant growth, driven by increasing consumer awareness about oral health and the importance of preventative care. The Non-prescription Mouthrinse market size is expected to expand substantially, with a promising growth forecast, as more individuals seek to maintain good oral hygiene and fresh breath.

Growth Drivers2 items

Rising demand for oral care products with natural ingredients and antimicrobial properties is driving the growth of the Non-prescription Mouthrinse market, as consumers become more health-conscious and seek effective solutions for maintaining good oral health.

Advances in technology and innovation are enabling the development of more effective and convenient Non-prescription Mouthrinse products, such as those with whitening and desensitizing properties, which is further fueling market growth.

Restraints2 items

Stringent regulations and compliance requirements are limiting the growth of the Non-prescription Mouthrinse market, as manufacturers must adhere to strict guidelines and standards for product safety and efficacy.

Intense competition in the Non-prescription Mouthrinse market is also a significant restraint, as established players and new entrants compete for market share and consumer loyalty.

Opportunities2 items

The growing trend towards personalized oral care and preventative medicine is creating new opportunities for the Non-prescription Mouthrinse market, as consumers seek tailored solutions for their specific oral health needs.

Expanding distribution channels and online sales platforms are also providing opportunities for manufacturers to reach a wider audience and increase their market share in the Non-prescription Mouthrinse market.

Challenges2 items

Managing supply chain disruptions and pricing pressures is a significant challenge for manufacturers in the Non-prescription Mouthrinse market, as they must balance profitability with the need to maintain competitive pricing and ensure consistent product availability.

Addressing consumer concerns about sustainability and environmental impact is also a key challenge, as manufacturers must develop eco-friendly packaging and formulations that meet the evolving expectations of environmentally conscious consumers in the Non-prescription Mouthrinse market.

Market Segmentation

Loading chart…

The Non-prescription Mouthrinse market can be segmented based on Application, which refers to the specific use cases of mouthrinse products. This segmentation category contributes to the overall market size by highlighting the various purposes for which non-prescription mouthrinse products are utilized, such as oral hygiene, bad breath prevention, and gum disease prevention. Understanding the application segment is crucial for manufacturers to develop targeted products that cater to specific consumer needs, ultimately driving the growth of the Non-prescription Mouthrinse market.

Another key segmentation category in the Non-prescription Mouthrinse market is Types, which includes subtypes such as antibacterial, antiplaque, and whitening mouthrinses. This segmentation category is essential in determining the market size, as different types of mouthrinses appeal to distinct consumer preferences and needs. For instance, consumers seeking to prevent gum disease may opt for antiplaque mouthrinses, while those looking to freshen their breath may choose antibacterial mouthrinses. Analyzing the types segment is vital for manufacturers to develop products that align with consumer demands, thereby influencing the overall Non-prescription Mouthrinse segmentation and market taxonomy.

Non-prescription Mouthrinse Segmentation Breakdown7 items

Application

Hypermarket and Supermarket

Convenience Stores

Online Sale

Types

Alcoholic

Non-alcoholic

Regional Insights

Loading chart…

The Non-prescription Mouthrinse market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the global market share. The fastest-growing region is anticipated to be Latin America, driven by increasing adoption of oral care products and rising investments in the healthcare sector.

Key drivers for each region include: for North America, policies supporting oral health and a mature ecosystem; for Europe, a high level of infrastructure and demographics favoring preventive care; for Asia Pacific, large populations and increasing demand for oral care products; for Latin America, growing middle-class populations and government initiatives; and for Middle East & Africa, rising awareness of oral health and expanding distribution channels.

The regional forecast indicates that Asia Pacific will continue to dominate the Non-prescription Mouthrinse market, while Latin America will experience the highest growth rate. Factors such as demographics, infrastructure, and ecosystem maturity will play crucial roles in shaping the market growth in each region.

Competitive Landscape

The Non-prescription Mouthrinse market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Non-prescription Mouthrinse competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios and strategic partnerships.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. Common differentiation strategies include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players' strategies include:

Johnson & Johnson: regional expansion

Sunstar: premium pricing

P&G: innovation pipeline

Colgate-Palmolive: local manufacturing

Unilever: OEM tie-ups

Lion: vertical integration

Key Non-prescription Mouthrinse Companies17 items

Johnson & Johnson

Sunstar

P&G

Lion

Colgate-Palmolive

Unilever

Church & Dwight

PIERAS CO

GSK

Caldwell Consumer Health

Weleda

Dentyl Active

Kao Corporation

NYSCPS

WEIMEIZI (GUANGDONG) CO.

Reckitt Benckiser Group Plc

SmartMouth Oral Health Laboratories

Market Ecosystem

The Non-prescription Mouthrinse ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream channels and end users. Value is created and captured as raw materials and components are transformed into finished products, which are then distributed to consumers through various channels. The ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where products are manufactured and integrated; and downstream, where products are distributed and sold to end users.

Raw material/component suppliers — provide ingredients and materials

OEMs / manufacturers — produce Non-prescription Mouthrinse products

Distributors / channel partners — manage logistics and sales

Service providers / after-sales — offer support and maintenance services

End users / buyers — purchase and use Non-prescription Mouthrinse products

Regulators/standards bodies — establish guidelines and standards

Data/analytics providers — provide market insights and research

In the Non-prescription Mouthrinse ecosystem, value flows through the various participants, with each stage influencing the next. Control points, such as regulatory approvals and distribution channels, can impact the adoption of Non-prescription Mouthrinse products. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem. Additionally, switching costs, partnerships, and interoperability requirements can influence the relationships between participants. As the ecosystem differs by region, with varying standards and regulations, participants must adapt to these differences to succeed in the global Non-prescription Mouthrinse market, requiring a thorough value chain analysis to navigate these complexities.

Recent Industry Insights

The Non-prescription Mouthrinse industry trends have witnessed significant developments over the last 12-18 months. Key players have been focusing on strategic partnerships, mergers, and acquisitions to expand their market share. For instance, companies have been collaborating to launch new products with advanced technologies, such as antibacterial and anti-inflammatory properties. Furthermore, there has been a notable shift in consumer trends, with a growing demand for natural and organic mouthrinse products.

Additionally, regulatory changes have been implemented to ensure the safety and efficacy of non-prescription mouthrinse products. The industry has also seen funding rounds and expansions, with companies investing in research and development to stay ahead of the competition. These developments are expected to drive growth in the non-prescription mouthrinse market, with the industry poised to experience significant advancements in the coming years.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Non-prescription Mouthrinse market outlook. The market attractiveness is moderate, driven by increasing consumer awareness of oral health and the desire for preventative care. Competitive intensity is high, with multiple established players and new entrants vying for market share.

The long-term outlook for the Non-prescription Mouthrinse market is positive, with opportunities for innovation in product formulation and delivery. The innovation landscape is evolving, with a focus on natural and sustainable ingredients. Demand-supply balance is currently stable, but key risk factors include regulatory changes and fluctuations in raw material costs.

11 items

1. Executive Summary

2. Non-prescription Mouthrinse Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-prescription Mouthrinse Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Non-prescription Mouthrinse Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hypermarket and Supermarket

6.1.2. Convenience Stores

6.1.3. Online Sale

6.2. Global Non-prescription Mouthrinse Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Alcoholic

6.2.2. Non-alcoholic

6.3. Global Non-prescription Mouthrinse Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Non-prescription Mouthrinse Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-prescription Mouthrinse Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-prescription Mouthrinse Market Competition by Key Manufacturers

8.1. Global Non-prescription Mouthrinse Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Non-prescription Mouthrinse: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Johnson & Johnson

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Sunstar

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. P&G

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Lion

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Colgate-Palmolive

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Unilever

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Church & Dwight

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. PIERAS CO

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. GSK

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Caldwell Consumer Health

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Weleda

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Dentyl Active

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Kao Corporation

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. NYSCPS

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. WEIMEIZI (GUANGDONG) CO.

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Reckitt Benckiser Group Plc

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. SmartMouth Oral Health Laboratories

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-prescription Mouthrinse Market

Figure 4: Global Non-prescription Mouthrinse Market: Drivers

Figure 5: Global Non-prescription Mouthrinse Market: Challenges

Figure 6: Global Non-prescription Mouthrinse Market: Trends

Figure 7: Global Non-prescription Mouthrinse Market: Opportunity

Figure 8: Global Non-prescription Mouthrinse Market: Restraint

Figure 9: Global Non-prescription Mouthrinse Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Non-prescription Mouthrinse Market Value (USD Million) By Region

Figure 15: Global Non-prescription Mouthrinse Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Non-prescription Mouthrinse Market Value (USD Million) By Region

Figure 23: Global Non-prescription Mouthrinse Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-prescription Mouthrinse Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-prescription Mouthrinse Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-prescription Mouthrinse Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Non-prescription Mouthrinse Market Value (USD Million) By Region

Table 10: Global Non-prescription Mouthrinse Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Non-prescription Mouthrinse Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Non-prescription Mouthrinse Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Non-prescription Mouthrinse Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Johnson & Johnson Basic Information And Sales Area

Table 31: Johnson & Johnson. Products Portfolio

Table 32: Sunstar Basic Information And Sales Area

Table 33: Sunstar. Products Portfolio

Table 34: P&G Basic Information And Sales Area

Table 35: P&G. Products Portfolio

Table 36: Lion Basic Information And Sales Area

Table 37: Lion. Products Portfolio

Table 38: Colgate-Palmolive Basic Information And Sales Area

Table 39: Colgate-Palmolive. Products Portfolio

Table 40: Unilever Basic Information And Sales Area

Table 41: Unilever. Products Portfolio

Table 42: Church & Dwight Basic Information And Sales Area

Table 43: Church & Dwight. Products Portfolio

Table 44: PIERAS CO Basic Information And Sales Area

Table 45: PIERAS CO. Products Portfolio

Table 46: GSK Basic Information And Sales Area

Table 47: GSK. Products Portfolio

Table 48: Caldwell Consumer Health Basic Information And Sales Area

Table 49: Caldwell Consumer Health. Products Portfolio

Table 50: Weleda Basic Information And Sales Area

Table 51: Weleda. Products Portfolio

Table 52: Dentyl Active Basic Information And Sales Area

Table 53: Dentyl Active. Products Portfolio

Table 54: Kao Corporation Basic Information And Sales Area

Table 55: Kao Corporation. Products Portfolio

Table 56: NYSCPS Basic Information And Sales Area

Table 57: NYSCPS. Products Portfolio

Table 58: WEIMEIZI (GUANGDONG) CO. Basic Information And Sales Area

Table 59: WEIMEIZI (GUANGDONG) CO.. Products Portfolio

Table 60: Reckitt Benckiser Group Plc Basic Information And Sales Area

Table 61: Reckitt Benckiser Group Plc. Products Portfolio

Table 62: SmartMouth Oral Health Laboratories Basic Information And Sales Area

Table 63: SmartMouth Oral Health Laboratories. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Application

Table 65: Global Market Share (%) By Application (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Types

Table 67: Global Market Share (%) By Types (2032)

Table 68: Global Non-prescription Mouthrinse Market Value (USD Million) By Region

Table 69: Global Non-prescription Mouthrinse Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Application

Table 72: North America Market Value (USD Million) (2025-2032) By Types

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Application

Table 75: Europe Market Value (USD Million) (2025-2032) By Types

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Application

Table 81: South America Market Value (USD Million) (2025-2032) By Types

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Non-prescription Mouthrinse Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.02 billion
Revenue forecast in 2033	3.52 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Sunstar; P&G; Lion; Colgate-Palmolive; Unilever; Church & Dwight; PIERAS CO; GSK; Caldwell Consumer Health; Weleda; Dentyl Active; Kao Corporation; NYSCPS; WEIMEIZI (GUANGDONG) CO.; Reckitt Benckiser Group Plc; SmartMouth Oral Health Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Intense competition in the Non-prescription Mouthrinse market is also a significant restraint, as established players and new entrants compete for market share and consumer loyalty.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Non-prescription Mouthrinse Segmentation Breakdown7 items

Application

Hypermarket and Supermarket

Convenience Stores

Online Sale

Types

Alcoholic

Non-alcoholic

Regional Insights

Loading chart…

Competitive Landscape

Johnson & Johnson: regional expansion

Sunstar: premium pricing

P&G: innovation pipeline

Colgate-Palmolive: local manufacturing

Unilever: OEM tie-ups

Lion: vertical integration

Key Non-prescription Mouthrinse Companies17 items

Johnson & Johnson

Sunstar

P&G

Lion

Colgate-Palmolive

Unilever

Church & Dwight

PIERAS CO

GSK

Caldwell Consumer Health

Weleda

Dentyl Active

Kao Corporation

NYSCPS

WEIMEIZI (GUANGDONG) CO.

Reckitt Benckiser Group Plc

SmartMouth Oral Health Laboratories

Market Ecosystem

Raw material/component suppliers — provide ingredients and materials

OEMs / manufacturers — produce Non-prescription Mouthrinse products

Distributors / channel partners — manage logistics and sales

Service providers / after-sales — offer support and maintenance services

End users / buyers — purchase and use Non-prescription Mouthrinse products

Regulators/standards bodies — establish guidelines and standards

Data/analytics providers — provide market insights and research

Recent Industry Insights

Analyst Overview

Table of Contents